Abstract:
In this study, thirty prostate cancer patient
examined in order to measure the function of bone
scan and PSA level in detection of prostate
carcinoma in case of staging cancer.
And to evaluate the value of radionuclide bone
scan and tumour marker. And to define the role and
methods of them.
It was found that twenty-three cases (76.7%)
out of thirty showed a positive bone scan, while
twenty-five cases (83.3%) out of thirty showed
abnormal PSA level